Home    Back

Oseltamivir    (DrugBank: Oseltamivir)

2 diseases
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis1
299Cystic fibrosis1

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1ChiCTR2000028767
2020-04-272020-01-03A randomized, controlled trial for evaluating the efficacy and safety of oseltamivir in the treatment of ulcerative colitisA randomized, controlled trial for evaluating the efficacy and safety of oseltamivir in the treatment of ulcerative colitis ulcerative colitisExperimental group:Oseltamivir and mesalazine;Control group:mesalazine;Xiangya Hospital of Central South UniversityNULLRecruiting1875BothExperimental group:53;Control group:53;N/AChina

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2009-016662-90-FR
(EUCTR)		03/11/200923/10/2009Etude de cohorte évaluant l'efficacité cliique, la tolérance et l'immunogénicité à la vaccination antigrippale pandémique chez les patients atteints de mucoviscidose et, le cas échéant, l'expression clinique de la grippe A (H1N1) et les facteurs associés à la survenue de formes sévères dans cette population. - Etude MUCOFLUEtude de cohorte évaluant l'efficacité cliique, la tolérance et l'immunogénicité à la vaccination antigrippale pandémique chez les patients atteints de mucoviscidose et, le cas échéant, l'expression clinique de la grippe A (H1N1) et les facteurs associés à la survenue de formes sévères dans cette population. - Etude MUCOFLU patients atteints de mucoviscidose
MedDRA version: 12.0;Level: LLT;Classification code 10011762;Term: Cystic fibrosis		Trade Name: Oseltamivir
Product Name: Vaccin grippal pandémique H1N1
INN or Proposed INN: Vaccin grippal pandémique H1N1		InsermNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		France